Typhim VI 25 MCG/0.5 ML syrng 0.5ML

Ended Awarded Last action

Contract number
SPE2DR26FBPPZ
Awardee
Awarding agency
Obligated
$23,808

Award facts

Contract value 100% obligated
$23,808.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Defense Logistics Agency issued a $23,808 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 24, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for TYPHIM VI 25 MCG/0.5 ML vaccine in syringe form.

PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical product supply to military healthcare facilities worldwide. The order carries a firm fixed price and ultimate completion date of February 25, 2026. Place of performance is Park Ridge, Illinois.

Quick answers

Who was awarded contract SPE2DR26FBPPZ?

SPE2DR26FBPPZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 24, 2026.

How much is contract SPE2DR26FBPPZ worth?

The government has obligated $23,808 on SPE2DR26FBPPZ.

Is contract SPE2DR26FBPPZ an order under another contract?

Yes. SPE2DR26FBPPZ is a delivery order under SPE2DR25D9309, an indefinite delivery contract.

Was contract SPE2DR26FBPPZ competed?

The extent of competition for SPE2DR26FBPPZ was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login